Both in Surgical Instruments
TELA Bio vs Nephros
Over the past year TELA returned −32.2% and NEPH returned −44.8%; their daily moves had a correlation of 0.05.
TELA −32.2% NEPH −44.8%Growth of $1, one year, split-adjusted
| Metric | TELA | NEPH |
|---|---|---|
| Price | $0.9760 | $3.17 |
| Market cap | $44.1M | $34.5M |
| Today | +1.67% | −9.69% |
| 1 month | −21.3% | −18.5% |
| 6 months | +13.5% | −2.2% |
| Year to date | −17.3% | −35.0% |
| 1 year | −34.1% | −41.5% |
| Revenue growth (YoY) | −4.5% | +36.2% |
| Gross margin | 72.3% | 66.9% |
| Net margin | −58.4% | 19.9% |
| P/E (TTM) | — | 19.8× |
| Price / sales | 0.6× | 1.7× |
| Net cash | -$25.7M | $4.7M |
| Dividend yield | — | — |
| Volatility (60d) | 88.9% | 79.7% |
| Short % of float | 2.0% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).